Biologic prescribing decisions following serious infection: Results from the British Society for Rheumatology Biologics Register—Rheumatoid Arthritis
Subesinghe S et al. Rheumatology (Oxford) 2018: key198. doi: 10.1093/rheumatology/key198
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.